Douglas Love is the founder of Annexon Biosciences. Latest round: Series A. Backed by New Enterprise Associates, Correlation Ventures, Novartis Venture Fund.
Douglas Love, Esq. is the Co-founder, President & CEO of Annexon Biosciences, a biotechnology company concentrating on complement-mediated diseases. He helped raise the company's Series A financing and has guided Annexon through clinical trials, including a Phase 2 study for eye disease medication ANX007.
Full founder directory · Investor directory · Company funding database · Fundraising library